Predicting the performance of a genetic testing service for cancer susceptibility

Genetic Testing

Volumn 11, Issue 4, 2007, Pages 381-386

  Bajdik, Chris D ^a,b   Sung, Steve ^a   Spinelli, John J ^a,b   Huntsman, David ^a,b   Gallinger, Steven ^c   Horsman, Douglas ^a,b   Gallagher, Richard P ^a,b  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; ARTICLE; CANADA; CANCER PREVENTION; CANCER SUSCEPTIBILITY; COMPUTER MODEL; COMPUTER PROGRAM; COST BENEFIT ANALYSIS; DIAGNOSTIC VALUE; FAMILY HISTORY; GENETIC SCREENING; HEALTH CARE PLANNING; HEALTH SERVICE; HUMAN; POPULATION GENETICS; PREDICTION; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE;

GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; NEOPLASMS;

EID: 38149138795     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/gte.2007.0031     Document Type: Article

References (18)

1. Antoniou A, Pharoah PDP, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thoralacius S, Eerola H, Nevanlinna H, Syrjakoski K, Kallionemi O-P, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF (2003) Average risks of breast and ovarian cancer associated with BRCA1 and BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studies. Am J Hum Genet 72:1117-1130.
2. Bapat B, Noorani H, Cohen Z, Berk T, Mitri A, Gallie B, Pritzker K, Gallinger S, Detsky AS (1999) Cost comparison of predictive genetic testing versus conventional clinical screening for familial adenomatous polyposis. Gut 44:698-703.
3. Breheny N, Geelhoed E, Goldblatt J, Ee H, O'Leary P (2006) Economic evaluation of the familial cancer programme in Western Australia: Predictive genetic testing for familial adenomatous polyposis and hereditary non-polyposis colorectal carcinoma. Community Genet 9:98-106.
4. Cancel-Tassin G, Cussenot O (2005) Genetic susceptibility to prostate cancer. Invest Urol 96:1380-1385.
5. Chikhaoui Y, Gelinas H, Joseph L, Lance JM (2002) Cost-minimization analysis of genetic testing versus clinical screening of at-risk relatives for familial adenomatous polyposis. Int J Technol Assess Health Care 18:67-80.
6. Griffith GL, Edwards RT, Gray J, Wilkinson C, Turner J, France B, Bennet P (2004) Estimating the survival benefits gained from providing national cancer genetic services to women with a family history of breast cancer, Br J Cancer 90:1912-1919.
7. James PA, Doherty R, Harris M, Mukesh BN, Milner A, Young M, Scott C (2006) Optimal selection of individuals for BRCA mutation testing: A comparison of available methods. J Clin Oncol 24:707-715.
8. Lawrence WF, Peshkin BN, Liang W, Issacs C, Lerman C, Mandelblatt JS (2001) Cost of genetic counseling and testing for BRCA1 and BRCA2 breast cancer susceptibility mutations. Cancer Epidemiol Biomarkers Prev 10:475-481.
9. Peto J, Collins N, Barfoot R, Seal S, Warren W, Rahman N, Easton DF, Evans C, Deacon J, Stratton MR (1999) Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst 91:943-949.
10. Plon SE, Nathanson K (2005) Inherited susceptibility for pediatric cancer. Cancer J 11:255-267.
11. Reyes CM, Allen BA, Terdiman JP, Wilson LS (2002) Comparison of selection strategies for genetic testing of patients with hereditary nonpolyposis colorectal carcinoma. Cancer 95:1848-1856.
12. Roa BB, Boyd AA, Volcik K, Richards CS (1996) Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet 14:185-187.
13. Rowley PT (2005) Inherited susceptibility to colorectal cancer. Annu Rev Med 56:539-554.
14. Secretary's Advisory Committee on Genetics, Health, and Society (2006) Coverage and Reimbursement of Genetic Tests and Services. Available at http://www4.od.nih.gov/oba/sacghs/reports/CR_report. pdf.
15. Statistics Canada (1993) Fertility. Catalogue no. 93-321.
16. Statistics Canada (1995a) Births and Deaths, 1995. Catalogue no. 84-210-XMB
17. Statistics Canada (1995b) Life Tables, Canada and Provinces, 1990-1992. Catalogue no. 84-537
18. Struewing JP, Abeliovich D, Peretz T, Avishai N, Kaback MM, Collins FS, Brody LC (1995) The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet 11:198-200.